Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Amarin Corporation plc (AMRN) has a Wall Street consensus price target of $2.17, based on estimates from 18 covering analysts. With the stock currently trading at $13.80, this represents a potential downside of -84.3%. The company has a market capitalization of $5.74B.
Analyst price targets range from a low of $1.50 to a high of $3.00, representing a 69% spread in expectations. The median target of $2.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, AMRN trades at a trailing P/E of -3.5x. Analysts expect EPS to grow +99.5% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how AMRN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonAMRN's consensus price target is $2.17, -84.3% below the current price of $13.8. The 18 analysts tracking AMRN see downside risk at present valuations.
AMRN has a consensus rating of "Hold" based on 18 Wall Street analysts. The rating breakdown is mixed, with 13 Hold ratings making up the largest segment. The consensus 12-month price target of $2.17 implies -84.3% downside from current levels.
AMRN's current price is $13.8 with a consensus target of $2.17 (-84.3% implied move). Analyst estimates suggest the stock is overvalued at current levels.
The most bullish Wall Street analyst has a price target of $3 for AMRN, while the most conservative target is $1.5. The consensus of $2.17 represents the median expectation. These targets typically reflect 12-month expectations.
AMRN is well covered by analysts, with 18 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 13 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AMRN stock forecast based on 18 Wall Street analysts shows a consensus price target of $2.17, with estimates ranging from $1.5 (bear case) to $3 (bull case). The median consensus rating is "Hold".
Analysts are cautious on AMRN, with 2 Sell ratings and a price target of $2.17 (-84.3% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AMRN analyst price targets range from $1.5 to $3, a 69% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2.17 consensus represents the middle ground.